Features of adherence to drug therapy elderly:the impact of the diseaseand form of the drug
(the results of research in the urban population of Ecuador)

English version České info

The problem of commitment to ongoing drug therapy is complex, multidimensional, it affects both patient and doctor, and also influenced by the form of the medication. The research was focused on revealing the peculiarities of commitment to the ongoing drug therapy in elderly patients depending on the nature of the disease and the form of the medicine. The research is based on a sample of the urban population of the Republic of Ecuador. 111 elderly patients were examined, the age of the respondents ranged from 65 to 74 years of age (the average age of 69.2+2.2 years and there were 49 men and 62 women). The elderly patients were interviewed using a purpose-made questionnaire. It was found out that among the elderly, the degree of commitment to drug therapy is 53.2 % and it is significantly lower than in middle aged patients, for whom the number stands at 78.4 %. The reasons for which the patient does not follow the prescribed treatment regimen can be grouped as follows: causes associated with the patient; social reasons; reasons related to the drugs; reasons related to issues of communication and interaction between the doctor and the patient. The commitment to drug therapy decreases in the elderly often based on the form in which the drug is administered, with eye drops, injectable forms of medicines, drugs directly contained in vials and large tablet forms of drugs being affected the worst.

Keywords:
elderly people – adherence to therapy – commitment – medicinal forms – forgetfulness – polypragmasy – polymorbidity

Autoři: K. Prashchayeu; Pobeda Padilla Ag; A. Ilnitski; Pobeda Padilla Va; E. Fesenko; T. Khadieva
Vyšlo v časopise: Geriatrie a Gerontologie 2015, 4, č. 4: 203-208
Kategorie: Původní práce/studie

Souhrn

Keywords:
elderly people – adherence to therapy – commitment – medicinal forms – forgetfulness – polypragmasy – polymorbidity

Zdroje

1. Young JB, Robinson M, Chell S, Sanderson D, et al. A whole system study of intermediate care services for older people. Age and Ageing 2005; 34(6): 577–583.

2. Bryant SL. The information needs and information seeking behaviour of family doctors. Health Information & Libraries Journal 2004; 21(2): 84–93.

3. Lichtenberg P, Heresco-Levy U. Nitzan U. The ethics of the placebo in clinical practice. Journal of Medical Ethics 2004; 30: 551–554

4. Shine KI. Health care quality and how to achieve it. Acad Med 2002; 77: 91–99.

5. Jing Jin, Grant Edward Sklar,Vernon Min Sen Oh, Shu Chuen Li: Factors affecting therapeutic compliance: A review from the patient’s perspective Ther Clin Risk Manag 2008; 4(1): 269–286.

6. Russell CL, Conn VS, Jantarakupt P: Older adult medication compliance. Am J Health Behav 2006; 30: 636–650.

7. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. JAMA 2005; 294: 716–724

8. Conn VS, Hafdahl AR, Cooper PS, et al. Interventions to improve medication adherence among older adults. Gerontologist 2009; 49: 447–462.